Glenmark Pharmaceuticals

1423.40

+10.90 (0.77%) tick

NSE

Buy Sell

NSE BSE

Last updated on 24 Apr 2025 01:32 PM

Open Demat account

Returns

5.98%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

39823.8

Earning Per Share

183.11

Dividend Yield

0.26%

P/E Ratio

5.23

P/B Ratio

1.66

Debt to Equity

0.10

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology. Its branded generics business has a significant presence in markets across emerging economies including India.

Similar Companies

Sun Pharmaceutical

1801.7 +12.90 (0.01%) tick

1Yr Returns

+20.39%

Cipla

1545.6 +11.90 (0.01%) tick

1Yr Returns

+9.69%

Mankind Pharma Limited

2573.7 +28.20 (0.01%) tick

1Yr Returns

+6.13%

Dr. Reddys Laboratories

1192.6 +6.60 (0.01%) tick

1Yr Returns

-0.34%

Lupin

2104.3 +14.80 (0.01%) tick

1Yr Returns

+32.24%